Acadian Asset Management LLC Catalyst Pharmaceuticals, Inc. Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$12.25 - $19.5 $10.5 Million - $16.8 Million	-860,904 Reduced 96.62%	30,153 $560,000
Q3 2022 Nov 14, 2022	SELL	$7.06 - $15.52 $3.53 Million - $7.77 Million	-500,509 Reduced 35.97%	891,057 $11.4 Million
Q3 2022 Nov 14, 2022	SELL	$7.06 - $15.52 $3.53 Million - $7.77 Million	-500,509 Reduced 35.97%	891,057 $11.4 Million
Q2 2022 Aug 09, 2022	SELL	$6.23 - $8.57 $810,790 - $1.12 Million	-130,143 Reduced 8.55%	1,391,566 $9.76 Million
Q1 2022 May 12, 2022	BUY	$5.31 - $8.31 $773,895 - $1.21 Million	145,743 Added 10.59%	1,521,709 $12.6 Million
Q4 2021 Feb 10, 2022	SELL	$5.21 - $7.45 $307,306 - $439,430	-58,984 Reduced 4.11%	1,375,966 $9.31 Million
Q3 2021 Nov 12, 2021	BUY	$4.85 - $6.04 $1.7 Million - $2.11 Million	349,859 Added 32.24%	1,434,950 $7.6 Million
Q2 2021 Aug 11, 2021	SELL	$4.29 - $6.05 $513,028 - $723,501	-119,587 Reduced 9.93%	1,085,091 $6.24 Million
Q1 2021 May 11, 2021	BUY	$3.45 - $4.69 $1.62 Million - $2.21 Million	470,649 Added 64.12%	1,204,678 $5.55 Million
Q4 2020 Feb 11, 2021	BUY	$2.97 - $3.83 $106,034 - $136,738	35,702 Added 5.11%	734,029 $2.45 Million
Q3 2020 Nov 09, 2020	SELL	$2.97 - $5.08 $6,634 - $11,348	-2,234 Reduced 0.32%	698,327 $2.07 Million
Q2 2020 Aug 12, 2020	SELL	$3.48 - $5.05 $569,279 - $826,109	-163,586 Reduced 18.93%	700,561 $3.24 Million
Q1 2020 May 11, 2020	BUY	$2.61 - $5.21 $637,925 - $1.27 Million	244,416 Added 39.44%	864,147 $3.33 Million
Q4 2019 Feb 06, 2020	BUY	$3.67 - $5.7 $1.47 Million - $2.28 Million	400,629 Added 182.85%	619,731 $2.32 Million
Q3 2019 Nov 07, 2019	BUY	$3.89 - $7.43 $555,048 - $1.06 Million	142,686 Added 186.72%	219,102 $1.16 Million
Q2 2019 Aug 08, 2019	BUY	$2.7 - $6.11 $206,323 - $466,901	76,416 New	76,416 $293,000
Q4 2018 Feb 07, 2019	SELL	$1.92 - $3.62 $45,204 - $85,229	-23,544 Closed	0 $0
Q3 2018 Oct 30, 2018	SELL	$2.81 - $3.78 $362,754 - $487,975	-129,094 Reduced 84.58%	23,544 $89,000
Q2 2018 Jul 24, 2018	BUY	$2.26 - $3.84 $344,961 - $586,129	152,638 New	152,638 $476,000

Others Institutions Holding CPRX

# of Institutions

326

Shares Held

94.6M

Call Options Held

19.1K

Put Options Held

51.1K

Black Rock Inc. New York, NY

18.7M
Shares

$385 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

8.04M
Shares

$166 Million
0.0% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

6.23M
Shares

$128 Million
2.3% of portfolio
State Street Corp Boston, MA

5.69M
Shares

$117 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

3.02M
Shares

$62.2 Million
0.01% of portfolio

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account